BioLife Solutions, Inc. BJX1.F Stock
BioLife Solutions, Inc. Price Chart
BioLife Solutions, Inc. BJX1.F Financial and Trading Overview
BioLife Solutions, Inc. stock price | 15.8 EUR |
Previous Close | 9.75 EUR |
Open | 9.85 EUR |
Bid | 10.4 EUR x 500000 |
Ask | 10.5 EUR x 500000 |
Day's Range | 9.75 - 9.75 EUR |
52 Week Range | 9.75 - 26.34 EUR |
Volume | 500 EUR |
Avg. Volume | 14 EUR |
Market Cap | 437.1M EUR |
Beta (5Y Monthly) | 1.621059 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.42 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 62.14 EUR |
BJX1.F Valuation Measures
Enterprise Value | 450.6M EUR |
Trailing P/E | N/A |
Forward P/E | 82.083336 |
PEG Ratio (5 yr expected) | 558.6 |
Price/Sales (ttm) | 2.694555 |
Price/Book (mrq) | 1.2151493 |
Enterprise Value/Revenue | 2.778 |
Enterprise Value/EBITDA | -13.133 |
Trading Information
BioLife Solutions, Inc. Stock Price History
Beta (5Y Monthly) | 1.621059 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 26.34 EUR |
52 Week Low | 9.75 EUR |
50-Day Moving Average | 17.81 EUR |
200-Day Moving Average | 19.2 EUR |
BJX1.F Share Statistics
Avg. Volume (3 month) | 14 EUR |
Avg. Daily Volume (10-Days) | 80 EUR |
Shares Outstanding | 43.49M |
Float | 34.45M |
Short Ratio | N/A |
% Held by Insiders | 2.00% |
% Held by Institutions | 92.32% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | June 30, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -51.42% |
Operating Margin (ttm) | -29.85% |
Gross Margin | 33.17% |
EBITDA Margin | -21.15% |
Management Effectiveness
Return on Assets (ttm) | -6.70% |
Return on Equity (ttm) | -21.82% |
Income Statement
Revenue (ttm) | 162.22M EUR |
Revenue Per Share (ttm) | 3.77 EUR |
Quarterly Revenue Growth (yoy) | -2.50% |
Gross Profit (ttm) | 54.07M EUR |
EBITDA | -34312000 EUR |
Net Income Avi to Common (ttm) | -83419000 EUR |
Diluted EPS (ttm) | -1.68 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 46.26M EUR |
Total Cash Per Share (mrq) | 1.06 EUR |
Total Debt (mrq) | 44.57M EUR |
Total Debt/Equity (mrq) | 12.66 EUR |
Current Ratio (mrq) | 3.039 |
Book Value Per Share (mrq) | 8.106 |
Cash Flow Statement
Operating Cash Flow (ttm) | -1077000 EUR |
Levered Free Cash Flow (ttm) | -2171625 EUR |
Profile of BioLife Solutions, Inc.
Country | Germany |
State | WA |
City | Bothell |
Address | 3303 Monte Villa Parkway |
ZIP | 98021 |
Phone | 425 402 1400 |
Website | https://www.biolifesolutions.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 466 |
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; ultra-low temperature mechanical freezers; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
Q&A For BioLife Solutions, Inc. Stock
What is a current BJX1.F stock price?
BioLife Solutions, Inc. BJX1.F stock price today per share is 15.8 EUR.
How to purchase BioLife Solutions, Inc. stock?
You can buy BJX1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioLife Solutions, Inc.?
The stock symbol or ticker of BioLife Solutions, Inc. is BJX1.F.
Which industry does the BioLife Solutions, Inc. company belong to?
The BioLife Solutions, Inc. industry is Medical Instruments & Supplies.
How many shares does BioLife Solutions, Inc. have in circulation?
The max supply of BioLife Solutions, Inc. shares is 45.3M.
What is BioLife Solutions, Inc. Price to Earnings Ratio (PE Ratio)?
BioLife Solutions, Inc. PE Ratio is now.
What was BioLife Solutions, Inc. earnings per share over the trailing 12 months (TTM)?
BioLife Solutions, Inc. EPS is -1.42 EUR over the trailing 12 months.
Which sector does the BioLife Solutions, Inc. company belong to?
The BioLife Solutions, Inc. sector is Healthcare.